Delivery Order SPE2DB22D3010-SPE2DB25FP3LG
Award Date 9/10/25
Potential Completion Date 9/11/25
Potential Value $9.7K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $19,526.18 to AmerisourceBergen Drug Corp for Enbrel 50 mg/mL syringes, with an ultimate completion date of July 25, 2025. This non-set-aside, competitively awarded contract reflects AmerisourceBergen's role as a critical pharmaceutical distributor supporting federal medical procurement. The award represents a firm fixed-price delivery order, consistent with the company's established pattern of fulfilling pharmaceutical supply...
- The Defense Logistics Agency awarded a $29,419.28 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Enbrel 50 mg/ml syringes. The contract, which carries an ultimate completion date of August 8, 2025, represents a non-set-aside, competitively awarded procurement with performance fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,030.79 for Enbrel 25 mg/0.5 mL syringes on July 29, 2025, with completion targeted for July 30, 2025. This firm fixed-price contract, with no set-aside designation, represents a competitive award for pharmaceutical supply to support federal medical procurement needs. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $70,857.49 to AmerisourceBergen Drug Corp for the supply of Enbrel 50 mg/ml syringes. This firm fixed price, competitively awarded contract was executed on September 2, 2025, with an ultimate completion date of September 3, 2025, and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. The delivery order carries no set-aside designation, reflecting the open competitive procurement process through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Enbrel 50 mg/ml syringes valued at $9,949.47 on July 21, 2025, with completion anticipated by July 22, 2025. This competitive, non-set-aside award utilizes firm fixed pricing under a delivery order contract type and is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of the company's role as a critical pharmaceutical supplier to the...
- The Defense Logistics Agency awarded a $58,286.34 delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Enbrel 50 mg/mL syringes. The contract employs firm fixed pricing with no set-aside designation and is scheduled for completion by August 5, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform work at its corporate office location. This delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite...
- The U.S. Defense Logistics Agency (DLA) awarded a $11,537.80 firm-fixed price Delivery Order contract to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the supply of ENBREL 50 MG/ML syringes and has a completion date of September 5, 2024. AmerisourceBergen is a major pharmaceutical distributor that provides a wide range of essential medical commodities to various federal agencies, including the military. This contract award is part of AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,168.81 to AmerisourceBergen Drug Corp for Enbrel 50 mg/ml syringes, with an ultimate completion date of July 31, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation to AmerisourceBergen's Corporate Office located in Conshohocken, Pennsylvania. The contract represents a continuation of pharmaceutical supply delivery under AmerisourceBergen's broader federal contracting...
- The Defense Logistics Agency awarded a $9,158.68 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Enbrel 50 mg/ml syringes. This is a firm fixed price, non-set-aside contract with an ultimate completion date of July 21, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a near-term pharmaceutical supply requirement within the military healthcare supply chain. This award is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $37,120.42 to AmerisourceBergen Drug Corp for the supply of Enbrel 50 mg/ml syringes. The contract is a firm fixed price delivery order with an ultimate completion date of August 20, 2025, and represents a non-set-aside competitive award. AmerisourceBergen's corporate office, located in Conshohocken, Pennsylvania, will serve as the place of performance. This delivery order is issued under AmerisourceBergen's larger Indefinite...